Itamar Medical reportedly inked a pair of distribution deals for its WatchPAT sleep apnea monitor in the U.S. and Japan with a pair of medical device giants, Medtronic (NYSE:MDT) and Philips Healthcare (NYSE:PHG). Medtronic already owns a 21.6% stake in Itamar whose origins date back to Itamar’s founding in 1997, Globes reported. Caesarea, Israel-based Itamar’s deal with the Minneapolis medtech giant involves the exclusive right to market the WatchPAT device to U.S. patients with atrial fibrillation, the newspaper reported. It’s slated to begin as a pilot program; if successful, the exclusivity kicks in, with Medtronic agreeing to a minimum purchase amount and to put down some cash for marketing the device, according to the newspaper. Henry Schein (NSDQ:HSIC) is slated to handle the logistics of distribution, according to the report.
Help employers find you! Check out all the jobs and post your resume.
